Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Two diabetes medications more beneficial in preventing major cardiovascular events

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Childhood inactivity linked to increased risk of liver disease by young adulthood

Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver disease and liver cirrhosis by young adulthood, a new study finds.

3 Jun 2024

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Study confirms garlic's significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

2 Jun 2024

Intermittent fasting with protein pacing trumps calorie restriction in gut health and weight loss

A recent study in Nature Communications found that intermittent fasting with protein pacing (IF-P) is more effective than continuous calorie restriction (CR) in improving gut microbiota and metabolomic profiles, leading to greater weight and fat loss.

2 Jun 2024

Discovery of promising protein candidate opens new avenues for treating metabolic disorders

A University of Saskatchewan (USask) research team's discovery of the additional health benefits of an appetite-suppressing protein has doubled the potential for scientists to find new avenues for treating obesity and metabolic disorders in animals and people.

28 May 2024

Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute decompensated cirrhosis, and 2-26% in post-liver transplant patients.

24 May 2024

New understanding of cancer drug's ability to prevent fat buildup in the liver

University of Oklahoma researchers have deepened their understanding of a drug's ability to prevent fat buildup in the liver, a condition that often occurs with obesity and can lead to serious fatty liver disease.

23 May 2024

Study links higher microplastic levels in urine to endometriosis risk

A study in Ecotoxicology and Environmental Safety finds higher levels of microplastics in urine samples from endometriosis patients compared to healthy individuals.

21 May 2024

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder will be presented this week at Digestive Disease Week (DDW) 2024.

21 May 2024

New study uncovers 17 genes driving clonal hematopoiesis and links to aging and disease

Researchers identified 17 new genes positively selected for clonal hematopoiesis in a large U.K. Biobank cohort, revealing their impact on aging and disease risks.

15 May 2024

Study finds 41% of people with long-term itchiness have fatigue

41% of people with long-term itchiness have fatigue, likely due to persistent sleep disruption, according to new research published in the British Journal of Dermatology. In comparison, only 22% of the control group had fatigue.

15 May 2024

Mouse-rat chimeras offer functional liver cells for transplantation

Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.

9 May 2024

Cross-species liver cell growth could represent a solution to transplant shortage

Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.

8 May 2024

Intermittent fasting halts liver disease progression and reduces cancer risk

Fatty liver disease often leads to chronic liver inflammation and can even result in liver cancer. Scientists from the German Cancer Research Center (DKFZ) and the University of Tübingen have now shown in mice that intermittent fasting on a 5:2 schedule can halt this development.

8 May 2024

Can monitoring and encouraging physical activity through phone-based apps improve glycemic control and weight loss in type 2 diabetes patients?

Whether a smartphone application (app) for maintaining personal health records encouraged physical activity, improved step counts, and glycemic control.

6 May 2024

Liver Disease News and Research

Further Reading

Two diabetes medications more beneficial in preventing major cardiovascular events

Childhood inactivity linked to increased risk of liver disease by young adulthood

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Intermittent fasting with protein pacing trumps calorie restriction in gut health and weight loss

Discovery of promising protein candidate opens new avenues for treating metabolic disorders

Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients

New understanding of cancer drug's ability to prevent fat buildup in the liver

Study links higher microplastic levels in urine to endometriosis risk

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

New study uncovers 17 genes driving clonal hematopoiesis and links to aging and disease

Study finds 41% of people with long-term itchiness have fatigue

Mouse-rat chimeras offer functional liver cells for transplantation

Cross-species liver cell growth could represent a solution to transplant shortage

Intermittent fasting halts liver disease progression and reduces cancer risk

Can monitoring and encouraging physical activity through phone-based apps improve glycemic control and weight loss in type 2 diabetes patients?

Natural compounds in gut microbiome show promise for inflammation treatment

Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

Scientists uncover a cell responsible for repairing damaged liver tissue

Study reveals global underassessment and undertreatment of chronic hepatitis B

Study reveals molecular changes in 19 organs due to exercise

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News